Unknown

Dataset Information

Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?


ABSTRACT: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths globally, with nearly half of patients detected in the advanced stages. This is due to the fact that symptoms associated with CRC often do not appear until the cancer has reached an advanced stage. This suggests that CRC is a cancer with a slow progression, making it curable and preventive if detected in its early stage. Therefore, there is an urgent clinical need to improve CRC early detection and personalize therapy for patients with this cancer. Recently, liquid biopsy as a non-invasive or nominally invasive approach has attracted considerable interest for its real-time disease monitoring capability through repeated sample analysis. Several studies in CRC have revealed the potential for liquid biopsy applicatio

SUBMITTER: Mirza S 

PROVIDER: S-EPMC9853908 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature